Insight Wins VMware North America 2022 Partner Value Award
Winner recognized for ability as a solutions integrator to drive business growth and ROI with…
Month: April 2022
Nomad Announces $22.4 Million Seed Round to Build More Secure Cross-Chain Interoperability
SAN FRANCISCO–(BUSINESS WIRE)–Nomad, a security-first cross-chain messaging protocol, today announced that it has raised approximately…
Prescriptive Data and JPMorgan Chase Optimize the Firm’s Energy Use and Sustainable Operations with Nantum OS Technology
Nantum OS will bring real-time artificial intelligence and machine learning to help JPMorgan Chase operate…
Voltus to Participate in the Water Tower Research Fireside Chat on April 19, 2022
SAN FRANCISCO & BOSTON–(BUSINESS WIRE)–Voltus, Inc. (“Voltus”), the leading distributed energy resource (DER) software platform,…
Doug Markham, Seasoned Insurance Industry Expert, Joins Wisedocs as Chief Operating Officer
MIAMI–(BUSINESS WIRE)–#healthtech–Wisedocs announces the onboarding of key leadership team member, Doug Markham, as Chief Operating…
Energy Dome Wins Prestigious BloombergNEF Pioneers 2022 Low-Carbon Technology Competition
Energy Dome’s long-duration energy storage technology is recognized for its ability to decarbonize the economy…
BNP Paribas Hires Carl Riccadonna as Chief U.S. Economist
Key Hire Demonstrates Bank’s Mission to Strengthen Americas Client Franchise NEW YORK–(BUSINESS WIRE)–BNP Paribas, the…
UpStream Moves to the Innovaccer Health Cloud to Accelerate Transformation of U.S. Healthcare
Innovative provider will use the Innovaccer Health Cloud’s unified patient record to support value-based, whole-person…
NCODA and XIFIN Launch New Initiative to Expand Oncology Patient Care Options
“NCODA Informatics Initiative Powered by VisualStrata” Helps Attract Clinical Trials for Oncology Practices and Bridges…
Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion Through Digital Self-Service
Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and…
Kalao integrates Ramp to drive the mainstream adoption of NFTs
London, UK: 14 April 2022 – Payments infrastructure provider Ramp has partnered with Kalao, a…
Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer’s Symposium; International Frailty and Sarcopenia Research Conference
April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases….
Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
SHANGHAI, China and REDWOOD CITY, Calif., April 14, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences…
Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency
– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Not Regularly Transfused, PYRUKYND® Significantly…
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share…
Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States
REDWOOD CITY, Calif., and SHANGHAI, China, April 14, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”,…
Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting
Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well…
Vaxart to Present at World Vaccine Congress Washington 2022 on April 20
SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022
MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
BOSTON, April 14, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…